Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,286.80
(
0.64%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.93
(
-0.72%
)
Bitcoin
74,129.89
(
0.25%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 106524

Thursday, 10/25/2012 4:18:50 PM

Thursday, October 25, 2012 4:18:50 PM

Post# of 257253
PFO closure didn’t prevent strokes in STJ trial that ran for nine (!) years:

http://www.bloomberg.com/news/2012-10-25/st-jude-device-to-close-heart-holes-fails-to-prevent-stroke.html

STJ picked up the AMPLATZER product in its 2010 acquisition of AGAM for $1.3B (#msg-55673504), and it’s reasonable to ask whether STJ ultimately obtained any value from that deal.

NMT Medical, another company pursuing the connection between PFO closure and stroke, went bankrupt in 2011 (#msg-62251315).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now